Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA).

BACKGROUND Aortic valve calcification (AVC) and mitral annular calcification (MAC) are highly prevalent and predictive of mortality in end-stage renal disease populations. Whether less severe kidney dysfunction is associated with AVC and MAC is uncertain. STUDY DESIGN Cross-sectional study. SETTING & PARTICIPANTS Ethnically diverse middle-aged adults without clinically apparent cardiovascular disease who participated in the Multi-Ethnic Study of Atherosclerosis. PREDICTOR Estimated glomerular filtration rate (eGFR), cystatin C, and microalbuminuria. OUTCOMES & MEASUREMENTS AVC and MAC were determined by means of computed tomography. Multivariable logistic regression evaluated the association of kidney function with AVC and MAC. RESULTS Of 6,785 participants, 10% had an eGFR less than 60 mL/min/1.73 m(2) (<1.0 mL/s/1.73 m(2)), mean cystatin C level was 0.9 +/- 0.2 mg/L, 7% had microalbuminuria (albumin >or= 30 mg/g), 15% had diabetes, 13% had AVC, and 9% had MAC. In adjusted analyses for AVC, eGFR less than 60 mL/min/1.73 m(2) (adjusted odds ratio, 1.23; 95% confidence interval, 0.99 to 1.14) and greater cystatin C concentrations (per SD increase; adjusted odds ratio, 1.06; 95% confidence interval, 0.99 to 1.14) had modest associations. Microalbuminuria was not associated independently with AVC (adjusted odds ratio, 1.11; 95% confidence interval, 0.89 to 1.40). For the MAC end point, associations of eGFR less than 60 mL/min/1.73 m(2) and greater cystatin C level differed by diabetes status (P for interaction = 0.1 and 0.02, respectively). In persons with diabetes, eGFR less than 60 mL/min/1.73 m(2) (adjusted odds ratio, 2.03; 95% confidence interval, 1.26 to 3.25) and greater cystatin C level (adjusted odds ratio, 1.38; 95% confidence interval, 1.14 to 1.68) were associated strongly, whereas no association was observed in subjects without diabetes (eGFR < 60 mL/min/1.73 m(2): adjusted odds ratio, 1.13; 95% confidence interval, 0.86 to 1.49; cystatin C: adjusted odds ratio, 1.03; 95% confidence interval, 0.93 to 1.13). The association of microalbuminuria with MAC (adjusted odds ratio, 1.37; 95% confidence interval, 1.06 to 1.76) did not differ by diabetes status (P for interaction = 0.2). LIMITATIONS There were few participants with severe kidney disease. CONCLUSIONS Impaired kidney function had only a modest association with AVC, whereas its association with MAC was observed only in persons with diabetes. Future studies should evaluate whether associations of kidney impairment with dystrophic calcification differ by diabetes status in other clinical settings and vascular beds.

[1]  S. Tett,et al.  Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children--a meta-analysis. , 2007, Clinical biochemistry.

[2]  R. Kronmal,et al.  Features of the Metabolic Syndrome and Diabetes Mellitus as Predictors of Aortic Valve Calcification in the Multi-Ethnic Study of Atherosclerosis , 2006, Circulation.

[3]  P. Chaves,et al.  Cardiovascular morbidity and mortality in community-dwelling elderly individuals with calcification of the fibrous skeleton of the base of the heart and aortosclerosis (The Cardiovascular Health Study). , 2006, The American journal of cardiology.

[4]  R. Kronmal,et al.  Reproducibility of CT measurements of aortic valve calcification, mitral annulus calcification, and aortic wall calcification in the multi-ethnic study of atherosclerosis. , 2006, Academic radiology.

[5]  D. Levy,et al.  Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study. , 2006, Journal of the American Society of Nephrology : JASN.

[6]  P. Raggi,et al.  Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. , 2005, Kidney international.

[7]  K. Hunt,et al.  Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes. , 2005, Kidney international.

[8]  Kiang Liu,et al.  Urine Albumin Excretion and Subclinical Cardiovascular Disease , 2005, Hypertension.

[9]  R. Nelson,et al.  Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. , 2005, Journal of the American Society of Nephrology : JASN.

[10]  W. Aronow,et al.  Prevalence of valve calcium and association of valve calcium with coronary artery disease, atherosclerotic vascular disease, and all-cause mortality in 137 patients undergoing hemodialysis for chronic renal failure. , 2005, The American journal of cardiology.

[11]  R. Detrano,et al.  Ethnic Differences in Coronary Calcification: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2005, Circulation.

[12]  R. Cooper,et al.  Association between chronic kidney disease and coronary artery calcification: the Dallas Heart Study. , 2005, Journal of the American Society of Nephrology : JASN.

[13]  R. Detrano,et al.  Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. , 2005, Radiology.

[14]  T. Larson,et al.  Using Serum Creatinine To Estimate Glomerular Filtration Rate: Accuracy in Good Health and in Chronic Kidney Disease , 2004, Annals of Internal Medicine.

[15]  V. Andreucci,et al.  Coronary artery calcification in patients with CRF not undergoing dialysis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  R. Toto Microalbuminuria: Definition, Detection, and Clinical Significance , 2004, Journal of clinical hypertension.

[17]  D. Levy,et al.  Kidney function is inversely associated with coronary artery calcification in men and women free of cardiovascular disease: the Framingham Heart Study. , 2004, Kidney international.

[18]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[19]  P. Aliabadi,et al.  Intact parathyroid hormone levels in renal insufficiency , 1995, Calcified Tissue International.

[20]  P. Raggi,et al.  Valvular calcification in hemodialysis patients randomized to calcium-based phosphorus binders or sevelamer. , 2004, The Journal of heart valve disease.

[21]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[22]  J. Woo,et al.  Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. , 2003, Journal of the American Society of Nephrology : JASN.

[23]  R. Kronmal,et al.  Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.

[24]  C. Otto,et al.  Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human Plasma , 2002, Circulation.

[25]  P. Raggi,et al.  Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. , 2002, Kidney international.

[26]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  P. Raggi,et al.  Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? , 2002, Journal of the American College of Cardiology.

[28]  S. Seliger,et al.  Gender and the progression of renal disease , 2001, Current opinion in nephrology and hypertension.

[29]  T. Mazzone,et al.  Increased prevalence of significant coronary artery calcification in patients with diabetes. , 2001, Diabetes care.

[30]  D. Fliser,et al.  Serum cystatin C concentration as a marker of renal dysfunction in the elderly. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  E. Mohler Are atherosclerotic processes involved in aortic-valve calcification? , 2000, The Lancet.

[32]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[33]  E. Randers,et al.  Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. , 1999, Scandinavian journal of clinical and laboratory investigation.

[34]  T. Callister,et al.  Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. , 1998, Radiology.

[35]  Sílvia Ribeiro,et al.  Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  R. Zinck,et al.  Cystatin C--a new marker of glomerular filtration rate in children independent of age and height. , 1998, Pediatrics.

[37]  R. Saracho,et al.  The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  Catherine M. Otto,et al.  Clinical Factors Associated With Calcific Aortic Valve Disease , 1997 .

[39]  E. Mohler,et al.  Detection of osteopontin in calcified human aortic valves. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[40]  M. Antos,et al.  Frequency of mitral annular calcification in patients on hemodialysis estimated by 2-dimensional echocardiography. , 1996, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti.

[41]  M. Ferguson,et al.  Osteopontin is expressed in human aortic valvular lesions. , 1995, Circulation.

[42]  C. Price,et al.  Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. , 1995, Kidney international.

[43]  R. Detrano,et al.  Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.

[44]  E. Maher,et al.  AORTIC AND MITRAL VALVE CALCIFICATION IN PATIENTS WITH END-STAGE RENAL DISEASE , 1987, The Lancet.

[45]  G. Berti,et al.  Enzymic creatinine assay: a new colorimetric method based on hydrogen peroxide measurement. , 1983, Clinical chemistry.

[46]  M. Tidd,et al.  Letter: Safeguards for healthy volunteers in drug studies. , 1975, Lancet.

[47]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[48]  J. Kassirer,et al.  Clinical evaluation of kidney function--glomerular function. , 1971, The New England journal of medicine.